Exploring the potential therapeutic significance of secukinumab for annular epidermolytic ichthyosis
European Journal of Dermatology · 2026-11 · 36 (6) · 00-00
DOI: 10.1684/ejd.2026.5184 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Dermatology, 2026-11. Verfasst von Yue Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei230000, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei230000, China.
- Department of Dermatology, Children's Hospital Affiliated to Fudan University, National Children's Medical Center, Shanghai, China.
Zitieren
APA
Zhang, Y., Chen, G., Cui, M., Zhang, G., Huang, H., Li, M., & Liang, B. (2026). Exploring the potential therapeutic significance of secukinumab for annular epidermolytic ichthyosis. European Journal of Dermatology, 36(6), 00-00. https://doi.org/10.1684/ejd.2026.5184
Vancouver
Zhang Y, Chen G, Cui M, Zhang G, Huang H, Li M, et al. Exploring the potential therapeutic significance of secukinumab for annular epidermolytic ichthyosis. European Journal of Dermatology. 2026;36(6):00-00. doi:10.1684/ejd.2026.5184
BibTeX
@article{Zhang2026,
author = {Zhang, Yue and Chen, Gang and Cui, Mengxing and Zhang, Guiyuan and Huang, Hequn and Li, Ming and Liang, Bo},
title = {Exploring the potential therapeutic significance of secukinumab for annular epidermolytic ichthyosis},
journal = {European Journal of Dermatology},
year = {2026},
volume = {36},
number = {6},
pages = {00--00},
doi = {10.1684/ejd.2026.5184}
}
EUVIMED